Aperio Group, LLC - INTERSECT ENT INC ownership

INTERSECT ENT INC's ticker is XENT and the CUSIP is 46071F103. A total of 172 filers reported holding INTERSECT ENT INC in Q1 2018. The put-call ratio across all filers is 0.43 and the average weighting 0.2%.

Quarter-by-quarter ownership
Aperio Group, LLC ownership history of INTERSECT ENT INC
ValueSharesWeighting
Q1 2020$208,000
-64.1%
17,584
-24.3%
0.00%
-50.0%
Q4 2019$579,000
+61.7%
23,237
+10.6%
0.00%
+100.0%
Q3 2019$358,000
+62.0%
21,018
+116.6%
0.00%0.0%
Q2 2019$221,000
-31.6%
9,703
-3.6%
0.00%0.0%
Q1 2019$323,000
+35.1%
10,068
+18.9%
0.00%0.0%
Q4 2018$239,000
+7.7%
8,471
+43.3%
0.00%0.0%
Q2 2018$222,000
+4.2%
5,912
+9.3%
0.00%0.0%
Q1 2018$213,0005,4100.00%
Other shareholders
INTERSECT ENT INC shareholders Q1 2018
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 1,332,773$27,828,0005.75%
First Light Asset Management, LLC 2,036,645$42,525,0002.82%
Altium Capital Management LP 141,856$2,962,0000.82%
PURA VIDA INVESTMENTS, LLC 909,660$18,994,0000.54%
Rock Springs Capital Management LP 1,080,200$22,555,0000.49%
Novo Holdings A/S 508,922$10,626,0000.44%
Davide Leone & Partners Investment Co Ltd. 109,240$2,281,0000.28%
PURA VIDA INVESTMENTS, LLC 256,800$5,362,0000.15%
Bellevue Group AG 617,968$12,903,0000.14%
Gyon Technologies Capital Management, LP 13,318$278,0000.12%
View complete list of INTERSECT ENT INC shareholders